Quiver Bioscience joins forces with Dup15q Alliance to develop ASO therapy for rare neurological disorder
Quiver Bioscience partners with the Dup15q Alliance to advance antisense oligonucleotide therapy for Dup15q syndrome. Discover how AI-driven research is shaping genetic medicine. Read More
Recursion Pharmaceuticals and Exscientia announce merger to transform drug development
Recursion Pharmaceuticals Inc. (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) have announced a landmark merger, combining their strengths to form a formidable entity in drug ... Read More
Eli Lilly and OpenAI forge pioneering alliance to combat antimicrobial resistance
Eli Lilly and Company (NYSE: LLY) has entered into a partnership with OpenAI to harness generative AI for the discovery of new antimicrobials, aiming to ... Read More